Clinical Trial Update: Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial testing consolidation nivolumab after concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Opdivo (nivolumab) (nivolumab)

Snippet

Sponsor: Yonsei University | Conditions: Locally Advanced Nasopharyngeal Carcinoma | Phase 2 | Status: RECRUITING